Ashiq Mubarack News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MacroGenics (MGNX) Q1 2024 Earnings Call Transcript

MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

United statesJon miller evercoreEtzer daroutPeter lawsonKelsey goodwinAshiq mubarackMayank mamtanib rileyKaveri pohlmanSilvan tuerkcanJon millerJonathan chang leerinkJim karrelsStephen willeyYigal nochomovitzScott koenigJonathan chang

Arcus Biosciences, Inc (NYSE:RCUS) Q1 2024 Earnings Call Transcript

Arcus Biosciences, Inc (NYSE:RCUS) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Jennifer jarrettBob goeltzKaveri pohlmanYigal nochomovitzJonathan millerAshiq mubarackPeter lawsonJuan jaenTerry rosenDimitry nuytenBiggest real estate companiesArcus biosciences incArcus biosciencesCall transcript mayArcus biosciences first quarterPia eaves

Mersana Therapeutics, Inc (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the Mersana Therapeutics Fourth Quarter 2023 Conference Call and Webcast. Currently, all participants are in listen-only mode.

Comunidad autonoma de catalunaMarty huberTara bancroftDolasynthen adcsJason fredetteAshiq mubarackColleen kusyBrian deschuytnerMartin huberJonathan changExchange commission onMerck kgaaMerck kgaEuropean society of gynecological oncologyCorporate communicationsMersana therapeutics inc

Fate Therapeutics, Inc (NASDAQ:FATE) Q3 2023 Earnings Call Transcript

Operator: Welcome to the Fate Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are mode.

Scott wolchkoEd dulacMichael yeeDaina grayboschAshiq mubarackYigal nochomovitzTyler van burenBob valamehrMemorial sloan kettering cancer centerFate therapeutics incProtocol design committee of lupus therapeuticsSociety for immunotherapy of cancer annual meetingLupus research allianceDevelopment officerFate therapeuticsCall transcript november

Mersana Therapeutics, Inc (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the Mersana Therapeutics Third Quarter 2023 Conference Call and Webcast. [Operator Instructions]. Please note, this call is being recorded.

Martin huberDolasynthen adcsJason fredetteJonathan changMarty huberColleen kusyBrian deschuytnerAshiq mubarackMerck kgaCorporate communicationsMerck kgaaMersana therapeutics incExchange commission onMersana therapeuticsCall transcript novemberMersana therapeutics third quarter